NLRP3炎症小体在慢性肾脏病发病中的多重功能
本文综述NLRP3炎症小体在慢性肾脏病(CKD)发病中的多重作用。经典NLRP3-ASC-caspase-1-IL-1β-IL-18轴通过调控肾脏坏死性炎症参与多种肾病病理生理。近期研究强调NLRP3不依赖炎症小体的功能在CKD进展中的作用,如纤维化重塑、肾小管上皮细胞凋亡和代谢途径。靶向炎症小体效应器(如IL-1受体拮抗剂和IL-1β)已获批用于NLRP3依赖性疾病,但尚无NLRP3拮抗剂获批。本文强调NLRP3在调控肾脏坏死性炎症和纤维化中的双刃剑功能,并亟需特异性NLRP3抑制剂。
要点
- NLRP3通过经典炎症小体轴调控肾脏坏死性炎症。
- NLRP3不依赖炎症小体的功能参与CKD纤维化、凋亡和代谢。
- 尚无NLRP3拮抗剂获批,亟需特异性抑制剂治疗CKD。
核心结论
- NLRP3在CKD中兼具促炎和促纤维化等不依赖炎症小体的双刃剑功能。
- 亟需特异性NLRP3抑制剂,因其对CKD治疗有广泛潜力。
研究设计与样本
- 综述,汇总多种实验模型和人类CKD中NLRP3功能的研究。
主要发现
- 经典NLRP3-ASC-caspase-1-IL-1β-IL-18轴参与多种肾病坏死性炎症。
- NLRP3不依赖炎症小体的功能参与纤维化组织重塑、肾小管上皮细胞凋亡和代谢途径。
- 靶向IL-1受体拮抗剂和IL-1β的药物已获批用于NLRP3依赖性疾病,但无NLRP3拮抗剂获批。
临床怎么用
- 关注NLRP3不依赖炎症小体的功能作为CKD治疗新靶点。
- 现有IL-1靶向药物可用于NLRP3依赖性疾病,但CKD需等待特异性NLRP3抑制剂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The NLRP3 inflammasome is a cytosolic multiprotein caspase-activating complex platform involved in innate immunity required for the maturation and release of interleukin (IL)-1β and IL-18. Both cytokines activate their respective receptors present on cells inside and outside kidneys, resulting in the release of other proinflammatory cytokines to set up an inflammatory milieu both within the kidney and systemically. The canonical NLRP3-ASC-caspase-1-IL-1β-IL-18 axis has been shown to contribute to the pathophysiology of several kidney diseases by regulating renal necroinflammation. However, many recent studies have emphasized the inflammasome-independent functions of NLRP3 in chronic kidney disease (CKD) pathogenesis. This review highlights the contribution of the inflammasome-independent functions of NLPR3, for example, in fibrotic tissue remodeling, in tubular epithelial cell apoptosis, and in metabolic pathways, during the development and progression of CKD in various experimental models and humans. Interestingly, therapies targeting the inflammasome effectors (e.g., IL-1 receptor antagonists and IL-1β) have been approved for therapeutic use for NLRP3-dependent diseases; however, no NLRP3 antagonists have been approved for therapeutic use until now. This review highlights the double-edged sword-like functions of NLRP3 in the regulation of renal necroinflammation and fibrosis and therefore emphasizes the urgent need for specific NLRP3 inhibitors because of the broad therapeutic potential they offer for the treatment of CKD.
引用
- Mulay SR. Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases. Kidney Int. 2019. PMID: 30922667. doi:10.1016/j.kint.2019.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。